Company intelligence / Profile preview

LTE Partners

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

LTE Partners is a private pooled investment vehicle and hedge fund advised by Melkonian Capital Management. Public descriptions indicate that it employs a multi-asset-class investment strategy focused on generating risk-adjusted returns rather than developing therapeutic products or healthcare services. The fund appears in SEC and related fund-filing databases and has been associated with healthcare investments as an investor, including historical ownership stakes in companies such as Progenics Pharmaceuticals. However, LTE Partners itself is not a biotech, pharma, or healthcare operating company.

Industry: Investors

Beyond the preview

Go deeper on LTE Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LTE Partners.

Explore the full profile